Dr. Clinton Enos
Dermatology (Dermatology Physician)
721 Fairfax Ave Ste 200
Norfolk, VA 23507
Who else practices at this address →
Norfolk city is a federal dental shortage area. About shortage areas
- Medicare participating
At a glance
- Medical school
- Eastern Virginia Medical School (2016)
- Years since graduation
- 10
- In the NPI registry since
- 2016
- Medicare patients seen, 2024
- 628
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2016Medical school: Eastern Virginia Medical School
- 2016Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Dermatology Physician primary
VA license 0101275278 · FL license ME151678 - Student in an Organized Health Care Education/Training Program
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Sentara Norfolk General Hospital Norfolk, VA
Medical groups
- Evms Academic Physicians and Surgeons Health Services Foundation (232 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 628
- Services billed
- 2,529
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Pathology examination of tissue using a microscope, intermediate complexity | 209 | 152 |
| Established patient office or other outpatient visit, 20-29 minutes | 191 | 147 |
| Established patient office or other outpatient visit, 30-39 minutes | 152 | 106 |
| Biopsy of related skin growth, first growth | 109 | 89 |
| Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | 63 | 21 |
| Destruction of precancer skin growth, 2-14 growths | 63 | 24 |
| Destruction of precancer skin growth, 1 growth | 56 | 46 |
| Destruction of skin growth, 1-14 growths | 45 | 38 |
| Biopsy of related skin growth, each additional growth | 45 | 27 |
| New patient office or other outpatient visit, 30-44 minutes | 44 | 44 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Remicade (infliximab) | 42 |
| Humira(Cf) Pen (adalimumab) Other prescribers in Norfolk, VA | 34 |
| Sodium Chloride (0.9 % sodium chloride) Other prescribers in Norfolk, VA | 30 |
| Gamunex-C (immune globul g/gly/iga avg 46) | 25 |
| Doxycycline Monohydrate Other prescribers in Norfolk, VA | 20 |
| Triamcinolone Acetonide Other prescribers in Norfolk, VA | 20 |
| Dupixent Pen (dupilumab) Other prescribers in Norfolk, VA | 18 |
| Ketoconazole Other prescribers in Norfolk, VA | 14 |
| Cosentyx Sensoready (2 Pens) (secukinumab) | 12 |
| Hydrocortisone Other prescribers in Norfolk, VA | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 3 companies reported 3 payments worth $249 in total to this clinician.
| Galderma Laboratories, L.P. | $133 |
|---|---|
| Amgen Inc. | $102 |
| AbbVie Inc. | $13.87 |
| Food and Beverage | $249 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $21,120 in research payments for these studies, mostly to the institutions running them.
- A Phase 3, Multicenter, Double-blind Maintenance Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-ASC…
Amgen Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.